netFormulary NHS
Isle of Wight
Formulary
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:

Chemotherapy drugs are frequently given in combination.

Disease specific protocols are approved at local and network level.

Only approved protocols should be used. All chemotherapy treatment decisions should be made by a consultant grade oncologist or haematologist, with input from the relevant multidisciplinary team. 

 Chemotherapy drugs, including oral therapies must be prescribed, dispensed and administered only by suitably trained staff. 

Paediatric cancer therapies are initiated and prescribed from tertiary cancer centres. The exception is maintenance treatment for some cancers, which is prescribed by designated paediatricians only.

Cancer Drugs Fund (CDF) - Drug List

Chapter Links...
 Details...
08.01  Expand sub section  Drugs for cytotoxic-induced side-effects
Calcium Folinate
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Mesna
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.01  Expand sub section  Alkylating drugs
Bendamustine
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA216: Bendamustine for CLL
Cytotoxic Drug Busulfan
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Chlorambucil
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Cyclophosphamide
(Chemotherapy)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Lomustine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Melphalan
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.02  Expand sub section  Anthracyclines and other cytotoxic antibiotics
Cytotoxic Drug Bleomycin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Doxorubicin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Doxorubicin (Caelyx®)
(Liposomal)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
Cytotoxic Drug Epirubicin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Mitomycin
(injection, bladder)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Mitoxantrone (Mitozantrone)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.03  Expand sub section  Antimetabolites
Cytotoxic Drug Azacitidine (Vidaza®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA218: azacitidine for myelodysplastic syndromes
Link  NICE TA399: Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts
Cytotoxic Drug Capecitabine (Xeloda®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin
Link  NICE TA191: Gastric cancer (advanced) - capecitabine
Link  NICE TA61: Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer
Cytotoxic Drug Cytarabine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Fludarabine Phosphate
(Fludara®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA119: Leukaemia (lymphocytic) - fludarabine
Cytotoxic Drug Fluorouracil
(Chemotherapy)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Gemcitabine (Gemzar®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA116: Breast cancer - gemcitabine
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
Cytotoxic Drug Mercaptopurine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Methotrexate
(Chemotherapy)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Pemetrexed (Alimta®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA135: Mesothelioma - pemetrexed disodium
Link  NICE TA181: Lung cancer (non-small cell, first line treatment) - pemetrexed
Link  NICE TA190: Lung cancer (non-small-cell) - pemetrexed (maintenance)
Link  NICE TA402: Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin
Cytotoxic Drug Raltitrexed (Tomudex®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.04  Expand sub section  Vinca alkaloids and etoposide to top
Cytotoxic Drug Etoposide
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Vincristine Sulphate
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Vindesine Sulphate
(Eldisine®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Vinorelbine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.05  Expand sub section  Other antineoplastic drugs
Atezolizumab
(Tecentriq®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable
Axitinib (Inlyta®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA333: Axitinib for advanced renal cell carcinoma
Ceritinib (Zykadia) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA395: Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
Link  NICE TA500: Ceritinib for untreated ALK-positive non-small-cell lung cancer
Cytotoxic Drug Eribulin (Halaven®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA423: Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
Ibrutinib
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA429 : Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
Link  NICE TA491: Ibrutinib for treating Waldenstrom’s macroglobulinaemia
Link  NICE TA502: Ibrutinib for treating relapsed or refractory mantle cell lymphoma
Ixazomib (Ninlaro®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA505: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma
Pablociclib (Ibrance®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Pembrolizumab
(Keytruda®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA357: Pembrolizumab for melanoma after ipilimumab
Link  NICE TA366: Pembrolizumab for advanced melanoma not previously treated with ipilimumab
Link  NICE TA428: Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy
Link  NICE TA531 : Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer
Ruxolitinib (Jakavi®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA386: Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
Trifluridine-tipiracil
(Lonsurf®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
08.01.05  Expand sub section  Bevacizumab
Bevacizumab (Avastin®)
(Oncology)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA285: Ovarian, fallopian tube and primary peritoneal cancer (recurrent advanced, platinum-sensitive or partially platinum-sensitive) - bevacizumab
08.01.05  Expand sub section  Bortezomib
Cytotoxic Drug Bortezomib (Velcade®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA129: Multiple myeloma - bortezomib
Link  NICE TA228: 1st line treatment of multiple myeloma
Link  NICE TA311: Bortezomib for induction therapy in multiple myeloma
Link  NICE TA370: Bortezomib for previously untreated mantle cell lymphoma
08.01.05  Expand sub section  Brentuximab vedotin
Brentuximab vedotin
(Adcetris®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA478: Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma
Link  NICE TA524 : Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
08.01.05  Expand sub section  Cetuximab to top
Cetuximab (Erbitux®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA439 : Cetuximab and panitumumab for previously untreated metastatic colorectal cancer
08.01.05  Expand sub section  Dacarbazine and Temozolomide
Cytotoxic Drug Dacarbazine
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
08.01.05  Expand sub section  Hydroxycarbamide
Cytotoxic Drug Hydroxycarbamide
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
CCG

 CCG commissioned:

Sickle Cell Anaemia - Siklos

 

 
Cytotoxic Drug Hydroxycarbamide
View adult BNF View SPC online View childrens BNF
Formulary
Red
NHS England

NHSE Commissioned:

Essential thrombocythaemia, myelofibrosis or polycythaemia with high risk of complications. 

 

As these indications are commissioned by NHSE they should not be prescribed in primary care

 
08.01.05  Expand sub section  Imatinab
08.01.05  Expand sub section  Panitumumab
08.01.05  Expand sub section  Platinum compounds to top
Cytotoxic Drug Carboplatin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Cisplatin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Oxaliplatin
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin
08.01.05  Expand sub section  Protein kinase inhibitors
Afatinib (Giotrif®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA310: Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer
Crizotinib (Xalkori®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA406: Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
Link  NICE TA422: Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cance
Erlotinib (Tarceva®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Everolimus (Afinitor®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA421: Everolimus with exemestane for treating advanced breast cancer after endocrine therapy
Link  NICE TA449 : Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
Gefitinib (Iressa®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA192: Lung cancer (non-small-cell, first line) - gefitinib
Link  NICE TA374: Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
Cytotoxic Drug Imatinib Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Only Glivec brand is part of the black triangle scheme

 
Nilotinib (Tasigna®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
Link  NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
Sorafenib (Nexavar®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA474: Sorafenib for treating advanced hepatocellular carcinoma
08.01.05  Expand sub section  Taxanes
Cytotoxic Drug Cabazitaxel (Jevtana®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA391: Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
Cytotoxic Drug Docetaxel (Taxotere®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and management
Link  NICE TA101: Prostate cancer (hormone-refractory) - docetaxel
Cytotoxic Drug Paclitaxel
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and management
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
08.01.05  Expand sub section  Topoisomerase I inhibitors
Cytotoxic Drug Irinotecan Hydrochloride
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Cytotoxic Drug Topotecan (Hycamtin®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA183: Cervical cancer (recurrent) - topotecan
Link  NICE TA184: Lung cancer (small-cell) - topotecan
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
08.01.05  Expand sub section  Trastuzumab
Cytotoxic Drug Trastuzumab (Herceptin®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA208: Gastric cancer (HER2-positive metastatic) - trastuzumab
Link  NICE TA257: in combination with an aromatase inhibitor for HER2 positive metastatic breast cancer
Link  NICE TA34: Breast cancer - trastuzumab
08.02  Expand sub section  Immunosuppressant therapy to top
08.02.03  Expand sub section  Anti-lymphocyte monoclonal antibodies
Rituximab Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Truxima and Rixathon brands are part of the black triangle scheme

 
08.02.04  Expand sub section  Other immunomodulating drugs
Lenalidomide Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund

Subject to individual patient enrolment in REVLIMID Risk Evaluation and Mitigation Strategy (REMS)  

 
Link  Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy TA171
Link  Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality TA322
Link  REVLIMID REMS
Nivolumab (Opdivo®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA384: Nivolumab for treating advanced (unresectable or metastatic) melanoma
Link  NICE TA400: Nivolumab in combination with ipilimumab for treating advanced melanoma
Link  NICE TA417: Nivolumab for previously treated advanced renal cell carcinoma
Link  NICE TA462 : Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma
Link  NICE TA483: Nivolumab for previously treated squamous non-small-cell lung cancer
Link  NICE TA484: Nivolumab for previously treated non-squamous non-small-cell lung cancer
Link  NICE TA490: Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy
Olaparib (Lynparza®)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
 
Link  NICE TA620: Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
Osimertinib (Tagrisso)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Link  NICE TA416: Osimertinib for treating locally advanced or metastatic EGFR T790M mutation-positive non-small-cell lung cancer
Thalidomide
(haematology)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Subject to individual patient enrolment in Thalomid Risk Evaluation and Mitigation Strategy (REMS)  

 
Link  THALOMID REMS
08.02.04  Expand sub section  Interferon Alfa
Interferon Alfa
(IntronA)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
08.02.04  Expand sub section  Interferon beta
Interferon Beta (Rebif®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA527: Beta interferons and glatiramer acetate for treating multiple sclerosis
08.02.04  Expand sub section  Interferon gamma to top
08.02.04  Expand sub section  BCG bladder instillation
08.02.04  Expand sub section  Canakinumab
08.02.04  Expand sub section  Dimethyl fumarate
08.02.04  Expand sub section  Fingolimod
08.02.04  Expand sub section  Histamine to top
08.02.04  Expand sub section  Lenalidomide, pomalidomide, and thalidomide
08.02.04  Expand sub section  Teriflunomide
08.03  Expand sub section  Sex hormones and hormone antagonists in malignant disease
08.03.01  Expand sub section  Oestrogens
Diethylstilbestrol
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
08.03.02  Expand sub section  Progestogens to top
Megestrol Acetate
(Megace®)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
08.03.03  Expand sub section  Androgens
08.03.04  Expand sub section  Hormone antagonists
08.03.04.01  Expand sub section  Breast cancer
Anastrozole
(Breast cancer)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Exemestane
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Letrozole
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Palbociclib (Ibrance®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA495: Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Ribociclib (Kisqali®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA496: Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Tamoxifen
(Breast cancer/ mastocytosis)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
08.03.04.02  Expand sub section  Gonadorelin analogues
Degarelix (Firmagon®)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Link  Degarelix Shared Care Agreement (SCA)
Link  IMOC Degarelix Letter
Link  NICE TA404: Degarelix for treating advanced hormone-dependent prostate cancer
08.03.04.02  Expand sub section  Anti-androgens to top
Abiraterone (Zytiga®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA259: Abiraterone for castration resistant prostate cancer
Link  NICE TA387:Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
Bicalutamide
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Cyproterone
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Enzalutamide (Xtandi®) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA316: Enzalutamide for prostate cancer
Link  NICE TA377: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
Flutamide (Drogenil®)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Goserelin (Zoladex®)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Leuprorelin Acetate
(Prostap® SR)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
Triptorelin
(Gonapeptyl Depot®)
View adult BNF View SPC online View childrens BNF
Formulary
Yellow
 
08.03.04.03  Expand sub section  Somatostatin analogues
Lanreotide
(Somatuline Autogel®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England

NHSE funded

 
Lanreotide
(Somatuline® LA)
View adult BNF View SPC online View childrens BNF
Formulary
Red
NHS England

NHSE funded

 
Octreotide
(Sandostatin Lar®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England

NHSE funded

 
Octreotide
(Sandostatin®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England

NHSE funded

 
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Drugs that may be initiated, stabilised and maintained by primary, secondary or tertiary care Secondary and tertiary care prescribing may be continued by primary care. [this does not indicate first/second line choice]  

Green Hospital

Items used by the Hospital but would not normally be continued into primary care. Primary care prescribers can change to GREEN first or second.   

Green plus

Initiation of drugs by primary care following written advice from secondary/ tertiary care advice.  

Yellow

Drugs that may be continued in primary care following initiation and stabilisation in secondary/tertiary care  

Amber

Items requiring a shared care agreement. These items should be initiated and stabilised by secondary or tertiary care. The GP should only be asked to take over prescribing through a formal shared care agreement. Secondary care will be expected to continue prescribing until the agreement is made.  

Red

Hospital/ Trust ONLY. These are items the secondary and tertiary care are responsible for prescribing and will need to continue to prescribe for long term maintenance. These items will NOT be prescribed in primary care. But primary care should be informed the patient is receiving these items. This will include NHSE funded items requiring repatriation.  

GP - Black

Items covered by NHSE ‘Should not prescribe in primary care list’ – See CCG policy on Drugs of limited clinical value  

GP - Grey

Grey List: Items covered by NHSE ‘Should not prescribe in primary care list’ that are not to be routinely prescribed but may be suitable in a defined population – See CCG policy on Drugs of limited clinical value  

netFormulary